Aydin Cemalettin, Ince Volkan, Otan Emrah, Akbulut Sami, Koc Cemalettin, Kayaalp Cuneyt, Yilmaz Sezai
Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya, Turkey.
Int Surg. 2013 Apr-Jun;98(2):170-4. doi: 10.9738/INTSURG-D-12-00035.1.
Allogeneic vascular grafts are often required for vascular reconstruction during living donor liver transplantation. Such grafts are obtained prior to use, making storage conditions a critical issue for maintaining the integrity of the tissue to ensure a successful transplantation. This study describes an optimized storage protocol currently in use at a high-volume liver transplant center. Twenty-nine allogeneic vascular graft tissues obtained during cardiovascular surgery or from cadaveric donors were stored respectively in sterile 50 mL of Ringer lactate solution, without any preservation solutions or antimicrobials, at -22°C for a maximum of 3 months. Prior to use in vascular reconstruction, grafts were thawed in 0.9% NaCl solution at 37°C, and 1 × 0.5-cm(2) tissue samples were collected for microbial culturing and viral serology. ABO compatibility was not performed for any patients receiving vascular grafts. During this prospective study, all 29 allogeneic vascular grafts were used for back-table vascular reconstruction in living donor liver transplantation procedures. A total of 16 grafts were from the saphenous vein, 10 were from the iliac vein, and 3 were from the iliac artery. Bacterial growth was not detected in any tissue samples taken from the stored grafts. No vascular graft-related complications occurred during the 5 months of follow-up. The successful vascular reconstructions achieved with all 29 study grafts demonstrate that the simple, inexpensive storage method described herein is feasible and safe. Randomized, controlled studies should be carried out to further optimize and standardize the technique.
在活体肝移植过程中,血管重建通常需要同种异体血管移植物。此类移植物在使用前获取,因此储存条件对于维持组织完整性以确保移植成功至关重要。本研究描述了一家大型肝移植中心目前正在使用的优化储存方案。从心血管手术中获取或来自尸体供体的29个同种异体血管移植物组织分别储存在50 mL无菌乳酸林格液中,不添加任何保存液或抗菌剂,在-22°C下最多储存3个月。在用于血管重建之前,移植物在37°C的0.9%氯化钠溶液中解冻,并采集1×0.5平方厘米的组织样本进行微生物培养和病毒血清学检测。接受血管移植物的所有患者均未进行ABO血型相容性检测。在这项前瞻性研究中,所有29个同种异体血管移植物均用于活体肝移植手术中的后台血管重建。共有16个移植物来自大隐静脉,10个来自髂静脉,3个来自髂动脉。从储存的移植物中采集的任何组织样本均未检测到细菌生长。在5个月的随访期间未发生与血管移植物相关的并发症。所有29个研究移植物均成功实现血管重建,表明本文所述的简单、廉价的储存方法是可行且安全的。应进行随机对照研究以进一步优化和规范该技术。